🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Please find the full-text here: journals.lww.com/cjasn/abstract…

💊😟ATT induced hepatitis management

IgA

Basics of GN (part 2) Clinical presentation correlates with location of injury & state of GBM 1. Epi/Subepithelial injury=nephrotic 2. GBM breach=RPGN 3. Subendothelial injury:acute/DPGN= nephritic 4. Subendothelial injury: chronic/MPGN & double contour= Nephritic-nephrotic

ANCA-negative pauci-immune GN is reported to occur in up to 30% of cases; in Europe, it has a prevalence of 1-5% of cases. Our multi-centre series reported the largest cohort of 132 cases and was just published in KIReports kireports.org/article/S2468-… Baseline char. are given!

#KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD bit.ly/3CAdvCA (FREE) Nisha Bansal MD Kerri Cavanaugh Cynthia Delgado Michelle Estrella cybele ghossein Holly Koncicki Wendy St. Peter Katherine Tuttle Jeffrey William National Kidney Foundation

Venous Thromboembolism Prevention in Nephrotic Syndrome: The Role of Aspirin, Vitamin K Antagonists, and Direct Oral Anticoagulants ca. 2025 from KIReports Sayna Norouzi, MD, FASN Richard J. Glassock Kenar Jhaveri Ayman Al Jurdi, MD FASN Amir Abdipour, MD, FASN Zohreh.Gh #Nephpearls 👉 kireports.org/article/S2468-…

Updates on Glomerular Diseases

🐉Snake bite and AKI 🥔🚫🚫🚫 ⚠️ AKI is a life-threatening systemic effect of snake envenomation ⬆️ Snake bites from familiesof Viperidae and Elapidae are the common causes of AKI 🧪🧪Enzymatic toxins in snake venom result in injuries to all kidney cell types including

ADPKD Progression Prevention KDIGO 2025 key points #ADPKD #CKD #KDIGO Aarthi Muthukumaran Manish Balwani Srikanth Bathini Dr. Divya Bajpai 🇮🇳 @Dr_Aravind_P_MD Sowrabha Rajanna Milagros Flores Elba Medina Subashri Dr. Hardik Patel 🩺💉 Dr Priti MD,FASN🇮🇳 (प्रिति) Afees, MD Jasmine Sethi Raja Ramachandran (राजा)

Treatment algorithm for nephrotic syndrome (NS) in children from onset ca. 2025 from KDIGO #Nephpearls 👉 kdigo.org/guidelines/nep…

In the REGENCY phase 3 trial, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, plus standard therapy provided significantly better renal responses than standard therapy alone in patients with lupus nephritis. Full trial results and Research Summary:

💎🫘Evaluation of renal stone disease in adults Stone analysis 🧐 Blood 🧪 labs Genetics 🧬 academic.oup.com/ndt/advance-ar… NDT Hans-Joachim Anders

Core Curriculum by Charmaine Lok, Theodore You, and Timmy Lee: Hemodialysis Vascular Access: Core Curriculum 2025 bit.ly/4ir8vAF (FREE)

The importance of identifying new and putative target antigens associated with membranous nephropathy: evidence from a Sardinian cohort doi.org/10.1093/ckj/sf…

Here are 10 lessons they don't teach in medical school (but should) that I've learned the hard way over the years. 🧵 (0/10)

Today is #IgANAwarenessDay! KDIGO is joining clinicians, patients, and researchers worldwide in raising awareness of IgA Nephropathy (#IgAN). Check out KDIGO IgAN resources below, and stay tuned for the KDIGO 2025 IgAN Guideline--coming this fall! Key Messages in IgAN:

Membranous nephropathy treatment standard 🧐What are the novel developments in the pathophysiology of MN including the identification of target antigens and current treatment standards for MN? 👇👇👇 doi.org/10.1093/ndt/gf…

This Core Curriculum explores commonly implicated pathophysiological mechanisms in kidney dysfunction in heart failure and discuss principles behind effective decongestion and assessment of adequacy of natriuresis: bit.ly/434spfa (FREE) Kevin Bryan Lo A. Janakiraman Janani Rangaswami

Understanding how diabetes affects the kidneys and exploring new treatment options is of critical importance. We present a special collection of articles on Diabetes and Kidney Disease: bit.ly/3wpQ6vg (FREE until July 1, 2025)